Evidence-based guideline: IV immunoglobulin in the treatment of neuromuscular disorders: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology
- PMID: 23008223
- DOI: 10.1212/01.wnl.0000420999.09001.f7
Evidence-based guideline: IV immunoglobulin in the treatment of neuromuscular disorders: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology
Comment on
-
Evidence-based guideline: intravenous immunoglobulin in the treatment of neuromuscular disorders [RETIRED]: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology.Neurology. 2012 Mar 27;78(13):1009-15. doi: 10.1212/WNL.0b013e31824de293. Neurology. 2012. PMID: 22454268 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical